The Asia-Pacific Glaucoma Society (APGS) was established to facilitate contact between glaucoma specialists in the region, to encourage collaborative research and service projects, to increase the opportunities for exchange of skills and knowledge in this rapidly advancing field, and to assist our comprehensive ophthalmological colleagues and other eye care workers (whether medically trained or not) to be up to date with advances in all aspects of glaucoma diagnosis and management.
Glaucoma is the cause of considerable blindness in Asia, and is associated with specific problems in this region: the epidemiology and natural history of this disease differs from that in developed countries elsewhere. In addition, people suffering from Glaucoma in Asia, may have different therapeutic outcomes from their western counterparts.
APGS membership is open to all glaucoma specialists, ophthalmologists, eye care health professionals, doctors with an interest in glaucoma/ophthalmology, researchers in glaucoma, and any incorporated association wishing to support the objectives of the Society.
Benefits of becoming a member will entail discounted registration to the congress, access to the APGC, engage with a wider network of glaucoma specialists, plus much more.
If you are interested in joining, visit the APGS website below to find out more!

About Singapore National Eye Centre
Singapore National Eye Centre (SNEC) was incorporated in 1989 and commenced operations in 1990. It is the designated national centre within the public sector healthcare network, and spearheads and coordinates the provision of specialised ophthalmological services with emphasis on quality education and research. Since its opening in 1990, SNEC has achieved rapid growth and currently manages an annual workload of more than 400,000 outpatient visits and 30,000 major eye surgeries.
Ten subspecialties in Cataract and Comprehensive Ophthalmology, Corneal and External Eye Disease, Glaucoma, Neuro-Ophthalmology, Oculoplastics, Pediatric Ophthalmology and Adult Strabismus, Refractive Surgery, Ocular Inflammation and Immunology, Medical Retina and Surgical Retina have been established to provide a full range of eye treatments from comprehensive to tertiary levels for the entire spectrum of eye conditions.
SNEC was accorded the Excellence for Singapore Award in 2003 for achieving excellence in Ophthalmology, thrusting Singapore into international prominence. In 2006, SNEC received the first Minister for Health Award for public health. Clinician scientists from Singapore National Eye Centre and Singapore Eye Research Institute were awarded the prestigious President’s Science and Technology Award in 2009, 2010, 2014 and 2019 for their outstanding contributions in translational, clinical and epidemiological research in cornea, retina, glaucoma and myopia.

About Singapore Eye Research Institute
Established in 1997, Singapore Eye Research Institute (SERI) is Singapore’s national research institute for ophthalmic and vision research. SERI’s mission is to conduct high-impact eye research that prevents blindness, low vision and major eye diseases common to Singaporeans and Asians. Over the last decade, SERI has conducted landmark research projects that have led to tangible outcomes, patient benefits, and success stories. It has paved the way for significant improvements in how eye diseases are treated and prevented, not just for Singaporeans or Asians, but on a global scale.
At its inception, SERI saw a national remit in ophthalmic and vision research, and till today, SERI ensures that its facilities and resources are open to researchers across Singapore so that the greatest benefit may be obtained from what is a relatively small clinical ophthalmology catchment area in Singapore.
SERI has grown from a founding team of five in 1997 to a faculty of more than 253 staff, encompassing clinician scientists, scientists, research fellows, PhD students and support staff. This makes SERI one of the largest research institutes in Singapore, as well as the largest eye research institute in the Asia Pacific region. SERI has also over 230 adjunct faculties from various eye departments, biomedical institutes and tertiary centres in Singapore. SERI has published an impressive array of 5,942 scientific papers, and has secured external peer-reviewed competitive grants. As of 31 March 2022, SERI’s faculty has been awarded with more than 1,425 national and international prizes and filed 188 patents.
As the research institute of the SNEC, and directly affiliated to the Yong Loo Lin School of Medicine, National University of Singapore, as well the Duke-NUS Medical School, SERI undertakes vision research in collaboration with local clinical ophthalmic centres and biomedical research institutions, as well as major eye centres and research institutes throughout the world.
SERI ranks first globally in terms of eye publications per capita, far ahead of the US, UK and Japan. With its impressive publication track record, SERI is comparable to renowned eye institutes, both regionally and internationally.
